Partnertm Sirolimus-Eluting Coronary Stent System Certifications: Ce

Backed by a team of diligent experts, we have been able to manufacture and supply a wide range of PartnerTM Sirolimus-eluting Coronary Stent System in New Delhi, Delhi, India.

Thin stainless steel strut provides favorable balance between radial force and easier endothelialization.

Sine wave plus 3-3-3 link contribute to flexible stent design, which offer good flexibility and compliance.

Large open cell design allows of excellent side branch access.

Precise positioning markers show the length of the stent, which ensure the accurate positioning of the stent.
Smooth and no crack-bridging surface of the polymer helps with better endothelialization, and guarantees patientsa safety.

90 days scientific drug releasing period effectively inhibits SMC migration and proliferation.

CLINICAL STUDIES
Long-term Outcomes of Patients with Coronary Heart Disease Treated with Domestic Sirolimus-eluting Partner Coronary Stent [1]

[1] Huo,Yong,et al. "Long-term outcomes of patients with coronary heart disease treated with domestic sirolimus-eluting Partner coronary stent." Chinese Journal of Interventional Cardiology 16.5 (2008): 243-245.

ORDERING INFORMATION:
Please contact our local distributors for detailed information.

Lepu Medical Group was established in 1999. It is specialized in developing, manufacturing and marketing the high-tech medical devices and equipment. Today, Lepu Medical has grown into a global leading group company in the fields of cardiovascular interventions, structural heart diseases, cardiac rhythm management, anesthesia and critical care, in vitro diagnostics and general surgery with products include coronary stents, dilatation balloon catheters, interventional accessories, occlusion devices, mechanical heart valves, electrophysiology catheters, pacemakers, in vitro diagnostic equipment and biomarkers, DSA systems and surgical staplers. In 2009, Lepu Medical successfully went public, and listed on ChiNext Shenzhen Stock Exchange Market (stock code: 300003). Lepucare India is a 100% owned subsidiary of Lepu Medical, with its office based in Delhi, which in importing and distribution of our own products, the current selling products including DES, BMS, Guiding Catheter, Balloons, Sheath and Inflation Device, and within 3 month already 50+ Indian hospitals have tested and commercially use our products, with positive feedbacks.

Product Image :-